CHICAGO: Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence-driven precision medicine, announced Friday it has acquired Paige, a digital pathology company known for pioneering FDA-cleared AI applications in cancer detection. The $81.25 million deal, primarily paid in Tempus common stock, positions Tempus to expand its oncology-focused dataset and technical capabilities. Founded in 2017,…
Tag: digital pathology
Sonic Healthcare signs deal to acquire Pathology Watch for $130 million
SYDNEY, AUSTRALIA: Sonic Healthcare (ASX: SHL) has signed binding agreements to acquire Pathology Watch, a medical technology business headquartered in Salt Lake City, Utah, USA, which has developed and commercialised an integrated, end-to-end digital pathology platform for skin pathology (dermatopathology). Pathology Watch was recently named as part of the Inc. 500 fastest growing private companies…
ContextVision likely to spin-off digital pathology business
STOCKHOLM, SWEDEN: ContextVision AB, a medical technology software company, is conducting a review of the company’s structure, and has initiated work assessing a spin-off of the Digital Pathology unit with a goal of listing the new entity on the Euronext Growth on the Oslo Stock Exchange. The review is expected to be concluded by the…